NEW YORK, Sept 8- Mathew Martoma, a former portfolio manager at billionaire Steven A. Cohen's SAC Capital Advisors LP hedge fund, was sentenced on Monday to nine years in prison for engaging in what authorities called the most lucrative insider trading scheme in U.S. history. District Judge Paul Gardephe in New York also ordered Martoma, 40, to forfeit $9.3 million.
NEW YORK, Sept 4- A federal judge on Thursday refused to throw out the insider trading conviction of former SAC Capital portfolio manager Mathew Martoma, saying the trial evidence "overwhelmingly demonstrated Martoma's guilt."
NEW YORK, Aug 14- A federal judge rejected billionaire investor Steven A. Cohen's bid to dismiss lawsuits by Elan Corp and Wyeth shareholders who claimed they lost money because his firm SAC Capital Advisors LP conducted insider trading in the drugmakers' stocks.
NEW YORK, June 27- Mathew Martoma, a former SAC Capital Advisors portfolio manager convicted of insider trading, should be sentenced to a "substantial" term of prison beyond the eight years recommended by probation officers, U.S. prosecutors argued Friday. In court papers filed in New York federal court, prosecutors urged U.S.
SAN DIEGO June 23- Dublin, Ireland- based Alkermes Plc has the low-tax domicile currently in vogue among multinational pharmaceutical companies but is not interested in being bought out as it nears the launch of new drugs, its chief executive said on Monday.
The probe into insider trading continues with authorities looking at a number of funds, including SAC Capital, a source tells CNBC.
SAC Capital's head trader testified that Steven Cohen had instructed him to start selling Elan stock in accounts that had "less visibility."
A key witness testified in Matthew Martoma's insider trading scandal that he provided Martoma with confidential information about a drug trial.
Jim Cramer has been a fan of this company for quite some time. But a good stock always needs new catalysts.
A former SAC Capital Advisors trader wants to cite in court some 2012 testimony given by the hedge fund's founder Steven Cohen, claiming it rebuts the government's case.
After two decades of research, a treatment that slows or reverses the progression of Alzheimer's has proved elusive. The aging of the global population makes the need more urgent.
Wednesday marks 45 days since the end of the second quarter, or as it's known in the financial community, "13F Day." Some of the world's biggest funds report their holdings.
A new development suggests big companies may be getting fed up with Washington. Really fed up.
Who’s best for the markets, Yellen or Summers? Wall Street debates while awaiting Obama’s pick for the next Fed chairman.
Cramer says a trio of recent deals demands attention.
Stocks kicked off the week on a weak note as investors hesitated to jump in ahead of the Federal Reserve meeting and a slew of key economic reports.
U.S. stock index futures ticked lower on Monday, ahead of the Federal Reserve meeting and another heavy week for second quarter earnings.
The Federal Reserve's taper talk may have rattled the financial markets but it has had one notable beneficiary: Mergers and acquisitions.
Some of the names on the move ahead of the open.
Eli Lustgarten of Longbow Research says Caterpillar is probably reaching a bottom and that if mining stabilizes it should be an up year for the stock. The key will be that earnings don't continue downward next year. Ann Duignan of JPMorgan weighs in.